Literature DB >> 334306

Prostacyclin (PGI2) inhibits the formation of platelet thrombi induced by adenosine diphosphate (ADP) in vivo [proceedings].

G A Higgs, S Moncada, J R Vane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 334306      PMCID： PMC1667653     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Growth rate in vivo of platelet thrombi, produced by iontophoresis of ADP, as a function of mean blood flow velocity.

Authors:  N Begent; G V Born
Journal:  Nature       Date:  1970-08-29       Impact factor: 49.962

2.  The chemical structure of prostaglandin X (prostacyclin).

Authors:  N Whittaker; S Bunting; J Salmon; S Moncada; J R Vane; R A Johnson; D R Morton; J H Kinner; R R Gorman; J C McGuire; F F Sun
Journal:  Prostaglandins       Date:  1976-12

3.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962
  3 in total
  8 in total

1.  Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977.

Authors:  E A Higgs; G A Higgs; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

Review 2.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

3.  Actions of alpha-, beta- and ganglion-blockade on the pressor responses to angiotensins I and II in the conscious rabbit [proceedings].

Authors:  K A Munday; A R Noble; B P Rowe
Journal:  J Physiol       Date:  1978-02       Impact factor: 5.182

4.  Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.

Authors:  J C McGiff; E G Spokas; P Y Wong
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

5.  Prostaglandins and thromboxane in the delayed phase of shock induced by Serratia marcescens endotoxin.

Authors:  J R Parratt; N Sharma; I J Zeitlin
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

6.  Anti-aggregatory effect of prostacyclin (PGI2) in vivo.

Authors:  B L Bayer; K E Blass; W Förster
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

7.  Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch.

Authors:  E A Higgs; G A Higgs; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

8.  Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells.

Authors:  H Parsaee; J R McEwan; S Joseph; J MacDermot
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.